Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

Efficacy and Safety of Phentermine/Topiramate in Youth and Young Adults with Hypothalamic Obesity

HOPTop

What is the goal of the study?

The purpose of this study is to evaluate how safe and effective the drug Qsymia (Phentermine/Topiramate or Ph/T) is for children, adolescents, and young adults with hypothalamic obesity. We will also evaluate if Ph/T helps with weight loss and changes in hunger in patients with hypothalamic obesity. Qsymia is FDA approved to treat adults with obesity (BMI of 30 kg/m2 or greater) and pediatric patients, aged 12 and older, with obesity (BMI in 95th %ile or greater).

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: